Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment.
Walle, Johan Vande; Delmas, Yahsou; Ardissino, Gianluigi; Wang, Jimmy; Kincaid, John F; Haller, Herman.
; 30(1): 127-134, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26995002
Atypical hemolytic uremic syndrome: from diagnosis to treatment.
Eculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension.
An Atypical Case of Atypical Hemolytic Uremic Syndrome.
Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab.
Humangenetik beim atypischen hämolytisch-urämischen Syndrom Rolle in Diagnostik und Therapie.
Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
Síndrome hemolítico urémico atípico en tratamiento con eculizumab. Casos clínicos.
Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.
Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
[Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].